IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOGoldline Pharmaceutical

About Goldline Pharmaceutical

Goldline Pharmaceuticals has engaged itself in marketing pharmaceutical products branded as 'Goldline'. The product line of Goldline can be categorized into five groups: Goldline Pharma: It includes a range of 42 products for specialties including Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology. Goldline Cardinal: It consists of a range of 54 products for the Specialty division in medical fields such as Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians. Goldline Aayushman: It consists of a range of 18 products for the Specialty division in medical fields such as Pediatricians, Child Specialists, Neonatologists, and General Practitioners. Goldline InLife: It includes a range of 22 products for the Specialty division in medical fields such as Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians. Goldline Wellness: It consists of a range of 10 products for Supportive care for patients undergoing chemotherapy for their illness. As the company does not manufacture any products, it collaborates with third parties which manufacture medicines according to market analysis and product specifications of the company. The firm does not produce any products but rather works with third-party producers who manufacture their products as per the firm's market research and product descriptions, thus ensuring quality and regulatory compliance.Their products are all marketed and sold using the Goldline brand name by our distribution partners who distribute the products to retailers and wholesalers. Currently, the firm uses 15 producers and 7 distribution firms for selling its products, and it also helps hospitals and healthcare institutions in procurement and supplies. The firm sells products in the states of Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.

Checklist Quality Analysis

Live IPOs

National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
Open  Close17th Sep 2026 - 21st Sep 2026
Issue Size22561.57 Cr
Min. Qty8 Shares
Issue Price₹ 1700.00
Live IPO
Antala Industries logo

Antala Industries

SME
Open  Close29th Oct 2026 - 5th Nov 2026
Issue Size22.98 Cr
Min. Qty2000 Shares
Issue Price₹ 62.00
Live IPO
Companies NameOpen - CloseIssue SizeMin. QtyIssue PriceApply
National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
17th Sep 2026 - 21st Sep 202622561.57 Cr8 Shares₹ 1700.00
Antala Industries logo

Antala Industries

SME
29th Oct 2026 - 5th Nov 202622.98 Cr2000 Shares₹ 62.00
See All Live IPOs
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Goldline Pharmaceutical

Goldline Pharmaceutical

Open Date

May 12, 2026

Close Date

May 14, 2026

listed

Min Investment

₹2,58,000

Lot Size

3000 Shares

Issue Size

₹11.61 Cr

Price Range

₹41 - ₹41

Listing Date

May 19, 2026

IPO Doc

RHP PDF

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

₹17(+41.46%)GMP
19.77%Prediction Listing Gain

Grey Market Premium (GMP) Trend

Goldline Pharmaceutical IPO - Issue Objectives

The company will use ₹8.35 crore for repayment of borrowings availed by it. Part of the IPO proceeds will be used for general corporate purposes and issue expenses

Repayment of debt

69.62%

General corporate purpose

30.38%

1

Repayment of debt

The company will use ₹8.35 crore for repayment of borrowings availed by it.

69.62%
2

General corporate purpose

Part of the IPO proceeds will be used for general corporate purposes and issue expenses

30.38%

IPO Subscription Status

QIB
180.22x
NII
1,662.39x
Total
840.81x

Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).

Financials of Goldline Pharmaceutical

In Cr.

Contact Details

Goldline Pharmaceutical

103, F-1, Leela Apartment, Shilpa HSG Society, Near Saptagiri Nagar, Shanidham, Narendra Nagar, Nagpur, Maharashtra - 440015.

+917122786666
info@goldlinepharma.in
https://goldlinepharma.in

Goldline Pharmaceutical IPO - FAQs

Goldline Pharmaceutical IPO is a SME IPO. The issue is priced at 41-₹43. The minimum order quantity is 3000 Shares. The IPO opens on 12 May, and closes on 14 May. TBA is the registrar for the IPO. The shares are proposed to be listed on SME.








IPO Timeline

  • Pre Apply2026-05-11
  • Bidding Starts2026-05-12
  • Bidding Ends2026-05-14
  • Allotment Finalisation2026-05-15
  • Release of Funds2026-05-18
  • Demat Transfer2026-05-18
  • Listing2026-05-19